113 related articles for article (PubMed ID: 1721934)
1. Analysis of prognostic factors in thymectomized patients with myasthenia gravis: correlation between thymic lymphoid cell subsets and postoperative clinical course.
Fujii N; Itoyama Y; Machi M; Goto I
J Neurol Sci; 1991 Oct; 105(2):143-9. PubMed ID: 1721934
[TBL] [Abstract][Full Text] [Related]
2. Two-color flow cytometric analysis of thymic lymphocytes from patients with myasthenia gravis and/or thymoma.
Ichikawa Y; Shimizu H; Yoshida M; Arimori S
Clin Immunol Immunopathol; 1992 Jan; 62(1 Pt 1):91-6. PubMed ID: 1370261
[TBL] [Abstract][Full Text] [Related]
3. Changes in peripheral blood lymphocyte subset frequencies in myasthenia gravis patients are related to immunosuppression.
Crosti F; Armanini M; Confalonieri P; Antozzi C; Mantegazza R
J Neurol; 1994 Feb; 241(4):218-22. PubMed ID: 8195820
[TBL] [Abstract][Full Text] [Related]
4. Altered thymic endocrine activity along with impairments of peripheral zinc metabolism and T-lymphocyte populations are associated with myasthenia gravis: a follow-up study.
Licastro F; Mocchegiani E; Fabris N; Rinaldi R; Bontempo G; Tonon C; Schiavina M; Costa AN; D'Alessandro R
J Neuroimmunol; 1997 Aug; 77(2):153-60. PubMed ID: 9258245
[TBL] [Abstract][Full Text] [Related]
5. Thymopoiesis, regulatory T cells, and TCRVbeta expression in thymoma with and without myasthenia gravis, and modulatory effects of steroid therapy.
Fattorossi A; Battaglia A; Buzzonetti A; Minicuci G; Riso R; Peri L; Scambia G; Evoli A
J Clin Immunol; 2008 Mar; 28(2):194-206. PubMed ID: 18000743
[TBL] [Abstract][Full Text] [Related]
6. Effect of thymectomy on human peripheral blood T cell pools in myasthenia gravis.
Sempowski G; Thomasch J; Gooding M; Hale L; Edwards L; Ciafaloni E; Sanders D; Massey J; Douek D; Koup R; Haynes B
J Immunol; 2001 Feb; 166(4):2808-17. PubMed ID: 11160348
[TBL] [Abstract][Full Text] [Related]
7. The distribution of parenchyma, follicles, and lymphocyte subsets in thymus of patients with myasthenia gravis, with special reference to remission after thymectomy.
Mori T; Nomori H; Ikeda K; Kobayashi H; Iwatani K; Kobayashi T
J Thorac Cardiovasc Surg; 2007 Feb; 133(2):364-8. PubMed ID: 17258565
[TBL] [Abstract][Full Text] [Related]
8. Effect of thymectomy on peripheral lymphocyte subsets in myasthenia gravis: selective effect on T-cells in patients with thymic atrophy.
Haynes BF; Harden EA; Olanow CW; Eisenbarth GS; Wechsler AS; Hensley LL; Roses AD
J Immunol; 1983 Aug; 131(2):773-7. PubMed ID: 6408188
[TBL] [Abstract][Full Text] [Related]
9. Factors influencing the outcome of transsternal thymectomy for myasthenia gravis.
Huang CS; Hsu HS; Huang BS; Lee HC; Kao KP; Hsu WH; Huang MH
Acta Neurol Scand; 2005 Aug; 112(2):108-14. PubMed ID: 16008537
[TBL] [Abstract][Full Text] [Related]
10. [Effects of thymectomy and glucocorticoid therapy on peripheral lymphocytes in myasthenia gravis].
Huang Y; Xu X; Lin J
Zhonghua Nei Ke Za Zhi; 1995 Aug; 34(8):514-7. PubMed ID: 8697907
[TBL] [Abstract][Full Text] [Related]
11. CD4
Kohler S; Keil TOP; Hoffmann S; Swierzy M; Ismail M; Rückert JC; Alexander T; Meisel A
Clin Immunol; 2017 Jun; 179():40-46. PubMed ID: 28286113
[TBL] [Abstract][Full Text] [Related]
12. Thymectomy and systemic lupus erythematosus (SLE).
Panarese A; D'Andrea V; Pironi D; Filippini A
Ann Ital Chir; 2014; 85(6):617-8. PubMed ID: 25919914
[TBL] [Abstract][Full Text] [Related]
13. HLA type is not indicative for the effect of thymectomy in myasthenia gravis.
Kuks JB; Lems SP; Oosterhuis HJ
J Neuroimmunol; 1992 Feb; 36(2-3):217-24. PubMed ID: 1732282
[TBL] [Abstract][Full Text] [Related]
14. Marked increase in CD44-highly positive cells in hyperplastic thymuses from patients with Myasthenia gravis.
Utsugisawa K; Nagane Y; Tohgi H
Muscle Nerve; 2000 Apr; 23(4):507-13. PubMed ID: 10716760
[TBL] [Abstract][Full Text] [Related]
15. Increase in differentiated type of T lineage cells in the myasthenic thymus: two-color fluorocytometric analysis.
Fujii N; Itoyama Y; Goto I
Ann Neurol; 1990 Jun; 27(6):642-6. PubMed ID: 2113791
[TBL] [Abstract][Full Text] [Related]
16. Two-year outcome of thymectomy with or without immunosuppressive treatment in nonthymomatous myasthenia gravis and its effect on regulatory T cells.
Jakubíková M; Piťha J; Marečková H; Týblová M; Nováková I; Schutzner J
J Neurol Sci; 2015 Nov; 358(1-2):101-6. PubMed ID: 26320610
[TBL] [Abstract][Full Text] [Related]
17. Role of positive selection of thymoma-associated T cells in the pathogenesis of myasthenia gravis.
Inada K; Okumura M; Shiono H; Inoue M; Kadota Y; Ohta M; Matsuda H
J Surg Res; 2005 Jun; 126(1):34-40. PubMed ID: 15916972
[TBL] [Abstract][Full Text] [Related]
18. Surface phenotypes of lymphoid cells altered in the human myasthenic thymus.
Machi M; Itoyama Y; Goto I; Kuroiwa Y
Neurology; 1988 Apr; 38(4):592-6. PubMed ID: 3258415
[TBL] [Abstract][Full Text] [Related]
19. Active ectopic thymus predicts poor outcome after thymectomy in class III myasthenia gravis.
Ambrogi V; Mineo TC
J Thorac Cardiovasc Surg; 2012 Mar; 143(3):601-6. PubMed ID: 22177829
[TBL] [Abstract][Full Text] [Related]
20. Pathomechanisms of paraneoplastic myasthenia gravis.
Ströbel P; Preisshofen T; Helmreich M; Müller-Hermelink HK; Marx A
Clin Dev Immunol; 2003 Mar; 10(1):7-12. PubMed ID: 14575152
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
